Ayurvedic management of ardhavbhedaka (migraine) - a case report
Abstract
Migraine, referred to as Ardhavbhedaka in Ayurveda, is a prevalent and incapacitating neurological condition marked by recurring episodes of severe headaches, typically on one side of the head. These migraine episodes are frequently accompanied by various symptoms, including nausea, vomiting, sensitivity to light (photophobia), and aversion to sound (phonophobia). While conventional medicine mainly employs pharmacological approach-es— such as analgesics, antiemetic’s, and preventative medications, these treatments often demonstrate limited effectiveness over the long term and can lead to considerable side effects. Consequently, many individuals ex-plore alternative or complementary therapies, such as Ayurveda, to manage their condition in a more compre-hensive way. This case report examines the Ayurvedic treatment of a 30-year-old woman diagnosed with recur-rent migraine attacks. Over the past three years, she has experienced 3 to 4 migraine episodes each month. Her treatment involved a combination of Ayurvedic therapies specifically aimed at balancing the doshas (especially Vata and Pitta), along with detoxification and rejuvenation strategies. The comprehensive treatment plan incor-porated herbal remedies, Panchakarma therapies, dietary modifications, and lifestyle adjustments tailored to the patient’s individual constitution and the underlying causes of her migraines. Key herbal treatments included Brahmi (Bacopa monnieri) for enhancing mental clarity and reducing stress,…
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.